FluxMPS™ RPMI 1640 w/o Sodium Pyruvate, Sodium Bicarbonate, Phenol Red: 1X Liquid

Product#: DCP-RPMI-PBR1X
$34.10
DCP-RPMI-PBR1X
Availability:
Ships in 1-2 Weeks

warning For Research Use Only (RUO). Not intended for clinical, diagnostic, or therapeutic use in humans.
verified ISO 13485 Certified Manufacturing

FluxMPS™ RPMI 1640

Contains L-Glutamine Contains Calcium Contains Magnesium Contains Glucose (2.0 g/L) Without Sodium Bicarbonate Without Phenol Red Without Sodium Pyruvate

FluxMPS™ DCP-RPMI-PBR1X is Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) 1X liquid RPMI 1640 formulated without sodium pyruvate, sodium bicarbonate, or phenol red — engineered for T cell, lymphocyte, and hematopoietic cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration.

  • High-purity RPMI 1640 with 2.0 g/L glucose and 300 mg/L L-glutamine as primary carbon/nitrogen sources
  • Glutathione (reduced), 1.0 mg/L — antioxidant support for redox-sensitive lymphocyte and hematopoietic cultures
  • Formulated without sodium pyruvate, sodium bicarbonate, or phenol red — a CO₂-independent, HEPES-bufferable base suited to open-system and imaging assays
  • Quadruple-stage filtration (0.1 µm Prefiltration I → 0.04 µm Final filtration I → 0.1 µm Prefiltration II → 0.04 µm Final filtration II) reaching a 0.04 µm final cut-off
  • Endotoxin release specification < 0.05 EU/mL (LAL, USP <85>), controlled per manufacturing batch
  • Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ
  • pH 7.4 (USP <791>); osmolality 230–270 mOsm/kg H2O (USP <785>)
CAT. NO.
DCP-RPMI-PBR1X | Cell Culture Media UNSPSC: 41116155 | Commodity: Molecular biology and cell culture growth media | (UNv260801)
RPMI 1640 w/o Sodium Pyruvate, Sodium Bicarbonate, Phenol Red — 1X Liquid
  • Glucose2000 mg/L (2.0 g/L)
  • L-Glutamine300 mg/L
  • Sodium PyruvateNot added (excluded)
  • pH (USP <791>)7.4
  • Osmolality (USP <785>)230–270 mOsm/kg H2O
  • Endotoxin (USP <85>)< 0.05 EU/mL
  • Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
  • Storage2–8°C, protect from light
  • Shelf Life12 months from date of manufacture, unopened
  • ShippingCold pack (gel packs), 2–8°C
ISO 13485:2016 USP <85> <785> <788> RUO
Why FluxMPS™

Engineered where standard media fails

Conventional 0.22 µm–filtered RPMI passes mycoplasma-sized organisms, subvisible particulates, and endotoxin fragments that activate TLR4 signaling and confound immune cell assays. FluxMPS™ is built to address these failure modes.

filter_alt

Microchannel-safe purity

0.04 µm final filtration with USP <788> Method 1 (light obscuration) particulate compliance. Low-particulate media suited to suspension immune cell OoC and flow cytometry workflows.

science

Immune cell–optimized formulation

RPMI 1640 contains reduced glutathione (antioxidant) and a balanced amino acid / vitamin profile developed for lymphocyte and hematopoietic cell culture.

water_drop

Ultrapure-grade water

Type 1 water, 18.2 MΩ·cm, with trace-metal and organic-carbon (TOC) control — minimizes contaminant carry-over from feed water into the finished formulation.

shield

Low endotoxin release specification

< 0.05 EU/mL (LAL, USP <85>) — formulated to help avoid LPS-driven TLR4 activation artefacts that can confound T cell and NK cell activation studies.

analytics

Rich nutrient profile

RPMI's specialized nutrient and vitamin profile for demanding immune cell types, delivered as a low-particulate formulation suitable for OoC platforms.

tune

Customization on demand

pH, nutrient concentrations, HEPES, and component modifications available on request. Contact support@diagnocine.com.

Purity Architecture

Quadruple-stage filtration system

Four serial filtration stages — two dedicated prefilter + final-filter pairs — reach a final 0.04 µm polish. Each 0.04 µm final filter is protected by its own dedicated 0.1 µm prefilter, giving the process full redundancy across the train.

  1. 1

    0.1 µm Prefiltration I — Large Particulate Removal

    Removes large aggregates and cell/protein debris; protects the first 0.04 µm cartridge.

  2. 2

    0.04 µm Final filtration I — Mycoplasma-Retentive Barrier

    First 0.04 µm pass; retains sub-micron particulates and mycoplasma-sized organisms (0.2–0.3 µm) that pass a standard 0.22 µm filter.

  3. 3

    0.1 µm Prefiltration II — Second Dedicated Prefilter

    A second, independent prefilter protecting the second 0.04 µm cartridge — full redundancy of the pre-filtration pair.

  4. 4

    0.04 µm Final filtration II — Polish

    Ultimate polishing filter; aseptic fill and finish under validated ISO Class 5 (Class 100) conditions.

Performance vs. conventional media

5×
Cleaner than 0.22 µm media by particulate count
0.04
µm Final pore size across 4 filtration passes
Sterility & Mycoplasma: No growth after 14-day incubation (USP <71>). Mycoplasma risk is mitigated by 0.1 µm mycoplasma-retentive filtration; product is not tested per lot via USP <63>.
Grade: This product is Microfluidics Suitable, filtered to a 0.04 µm final cut-off. It is not an MPS Grade product — that designation is reserved for the 0.01 µm ultra nano-filtered line, which adds 0.02 µm and 0.01 µm stages after the 0.04 µm polish. For applications requiring the 0.01 µm cut-off, contact support@diagnocine.com.
FluxMPS DCP-RPMI-PBR1X RPMI 1640 Quadruple-stage filtration system diagram - 0.1 micron x2 and 0.04 micron x2 filtration for organ-on-a-chip, microfluidic and MPS cell culture applications - Diagnocine
Figure 1. FluxMPS™ Quadruple-stage filtration system (0.1 µm ×2 + 0.04 µm ×2).
© Diagnocine® — DCP-RPMI-PBR1X
Applications

Immune cell OoC and hematopoietic applications

FluxMPS™ DCP-RPMI-PBR1X — RPMI 1640 — delivers 0.04 µm filtered purity for hematopoietic cell, lymphocyte, and related OoC applications.

Automated Bioreactors & Robotics

Next-Generation System Uptime

An optional 0.01 µm (10 nm) MPS Grade ultra-filtered variant of this formulation is available on request for automated perfusion and robotics platforms.

  • Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates
  • Valve & Sensor Protection: Reduces micro-fouling risk in automated perfusion systems
  • Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture

Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.

Immunology

T Cell & Lymphocyte Culture

RPMI 1640 is the standard base for primary T cells, B cells, NK cells, and monocytes. 0.04 µm filtration reduces the particulate load that can drive TLR4 activation and confound immune assays.

T cellsB cellsNK cellsPBMC
Cancer Biology

Leukemia & Lymphoma Lines

RPMI supports NCI-60 cancer lines, Jurkat, Raji, K562, HL-60, and hematopoietic cancer lines where DMEM-based media would alter proliferation and signaling.

JurkatRajiK562HL-60
Microfluidics

Immune Cell OoC

0.04 µm filtered RPMI for tumor-immune interaction chips, vascular-immune OoC, and lymph node-on-chip models, where low-particulate media supports consistent cell behavior.

Tumor-immune chipLymph node OoCMPS
Immunotherapy

CAR-T & TIL Expansion

Low endotoxin release specification (< 0.05 EU/mL) supports CAR-T manufacturing and TIL expansion protocols sensitive to LPS-driven T cell activation artefacts.

CAR-TTILTCR-T
Metabolomics

Immune Cell Metabolic Flux

Bicarbonate-free, phenol red–free RPMI base compatible with Agilent Seahorse XF T cell metabolic assays, glycolysis stress tests, and ¹³C isotope tracing of lymphocyte activation states.

Seahorse XF¹³C tracingGlycolysis
Live-Cell Imaging

Flow Cytometry & Confocal

Ultra-low particulate baseline supports PE-channel flow cytometry and immune cell confocal imaging; phenol red is excluded from this formulation, reducing spectral interference in fluorescence channels.

Flow cytometryConfocalELISA
Technical Specifications

Analytical release specifications

Every lot released against the full specification matrix below. CoA available on request: support@diagnocine.com.

Physical & Chemical Parameters
Parameter Specification
Formulation [+] L-Glutamine, [+] Calcium, [+] Magnesium, [+] Glucose (2.0 g/L) | [-] Sodium Pyruvate, [-] Sodium Bicarbonate, [-] Phenol Red
Appearance Pale yellow-colored, clear solution
Glucose 2000 mg/L (2.0 g/L)
L-Glutamine 300 mg/L
pH USP <791> 7.4
Osmolality USP <785> 230–270 mOsm/kg H2O
Total ingredients 38
Sterility, Purity & Safety Parameters
Parameter Specification
Endotoxin USP <85> BET < 0.05 EU/mL
Sterility USP <71> No growth / 14 days
Mycoplasma 0.1 µm mycoplasma-retentive filtration (not tested per lot)
Particulate ≥10 µm USP <788> Method 1 NMT 25/mL
Particulate ≥25 µm USP <788> Method 1 NMT 3/mL
Water purity Type 1, 18.2 MΩ·cm
Manufacturing std. ISO 13485:2016
Fill environment ISO Class 5 (Class 100)
Storage, Handling & Logistics
Parameter Specification
Storage temperature 2–8°C, protect from light
Freeze-thaw Do not freeze
Shelf life 12 months from date of manufacture, unopened
Shipping condition Cold pack (gel packs), 2–8°C
CO₂ requirement CO2-independent; supplement with HEPES (15–25 mM) for pH buffering outside CO2 incubation
Raw Materials & Regulatory Traceability
Parameter Specification
Raw material grade Reagent / cell culture grade
Traceability Full lot traceability per ISO 13485
Manufacturing QMS ISO ISO 13485:2016 certified
UNSPSC 41116155 — Molecular biology and cell culture growth media (UNv260801)
Regulatory alignment 21 CFR Part 820 (QMSR) aligned
Production method Micro-batch, per-lot QC release
Intended use Research Use Only (RUO)
Available pack sizes 500 mL, 1000 mL
Formulation

Full composition (mg/L)

RPMI 1640: 38 ingredients verified per lot with CAS numbers for full raw-material traceability. This formulation contains reduced glutathione (antioxidant) and a balanced profile of vitamins and amino acids optimized for lymphocyte and hematopoietic cell culture.

Component CAS Number mg/L
INORGANIC SALTS
Calcium nitrate tetrahydrate 13477-34-4 100.000
Magnesium sulphate anhydrous 7487-88-9 48.840
Potassium chloride 7447-40-7 400.000
Sodium chloride 7647-14-5 6000.000
Sodium phosphate dibasic anhydrous 7558-79-4 800.000
Component CAS Number mg/L
AMINO ACIDS
Glycine 56-40-6 10.000
L-Arginine hydrochloride 1119-34-2 241.000
L-Asparagine 70-47-3 50.000
L-Aspartic acid 56-84-8 20.000
L-Cystine dihydrochloride 30925-07-6 65.200
L-Glutamic acid 56-86-0 20.000
L-Glutamine 56-85-9 300.000
L-Histidine hydrochloride monohydrate 5934-29-2 20.960
L-Hydroxyproline 51-35-4 20.000
L-Isoleucine 73-32-5 50.000
L-Leucine 61-90-5 50.000
L-Lysine hydrochloride 657-27-2 40.000
L-Methionine 63-68-3 15.000
L-Phenylalanine 63-91-2 15.000
L-Proline 147-85-3 20.000
L-Serine 56-45-1 30.000
L-Threonine 72-19-5 20.000
L-Tryptophan 73-22-3 5.000
L-Tyrosine Disodium Salt 69847-45-6 28.830
L-Valine 72-18-4 20.000
Component CAS Number mg/L
VITAMINS
Choline chloride 67-48-1 3.000
D-Biotin 58-85-5 0.200
D-Ca-Pantothenate 137-08-6 0.250
Folic acid 59-30-3 1.000
Niacinamide 98-92-0 1.00
Pyridoxine hydrochloride 58-56-0 1.00
Riboflavin 83-88-5 0.200
Thiamine hydrochloride 67-03-8 1.000
Vitamin B12 68-19-9 0.005
p-Amino benzoic acid (PABA) 150-13-0 1.000
OTHERS
D-Glucose 50-99-7 2000.000
Glutathione reduced 70-18-8 1.000
i-Inositol 87-89-8 35.000
Custom formulation: Contact support@diagnocine.com for DCP-RPMI-PBR1X modifications.
Quality Assurance

Manufacturing & compliance

Every FluxMPS™ product is manufactured and released under a multi-layer quality system.

verified

ISO 13485:2016 Quality Management

Manufactured under an ISO 13485:2016-certified quality management system. Final QC at Diagnocine R&D Center, Totowa, NJ, USA.

water_drop

Ultrapure Type 1 Water

18.2 MΩ·cm Type 1 water with trace-metal and organic-carbon (TOC) control.

biotech

ISO Class 5 Fill & Finish

Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.

assignment

Micro-Batch Precision

Small-batch, per-lot tested — no blending; Certificate of Analysis available for every batch.

Endotoxin — USP <85> BET

LAL assay; release specification < 0.05 EU/mL.

Particulate — USP <788> Method 1

Light obscuration count: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).

Osmolality — USP <785>

Target: 230–270 mOsm/kg H2O.

Documentation & CoA

Full CoA with raw-material traceability available on request.

Batch-level quality control. Endotoxin is controlled per manufacturing batch rather than per unit. Every batch is tested before release and must meet the release specification:
  • Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
  • pH, osmolality, conductivity, appearance and clarity
  • Sterility
A Certificate of Analysis is available on request at support@diagnocine.com.
Product Comparison

How DCP-RPMI-PBR1X compares

FluxMPS™ DCP-RPMI-PBR1X vs. published specifications from other cell culture media suppliers.

Parameter DCP-RPMI-PBR1X (FluxMPS™) Other Suppliers (published specifications)
Grade Microfluidics Suitable Not specified
Formulation RPMI 1640 w/o sodium pyruvate, sodium bicarbonate, phenol red — CO2-independent, imaging-clean base with L-glutamine Not specified
Final filtration pore size 0.04 µm Not specified
Number of filtration stages 4 (Quadruple-stage) Not specified
Mycoplasma barrier filtration check_circle Yes (0.1 µm mycoplasma-retentive stage) Not specified
Endotoxin (release specification) < 0.05 EU/mL Corning classical liquid media — < 0.25 EU/mL
Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL
Gibco classical DMEM — Not specified (recorded per lot)
USP <788> particulate compliance check_circle Yes (Method 1) Not specified
Water quality Type 1, 18.2 MΩ·cm Not specified
Manufacturing QMS ISO 13485:2016 Not specified
Microfluidic channel compatibility check_circle Microfluidics Suitable Not specified
Custom formulation check_circle Yes, on request Not specified

Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".

FAQ

Frequently asked questions

Common questions about FluxMPS™ DCP-RPMI-PBR1X — RPMI 1640.

Yes. DCP-RPMI-PBR1X is processed through a quadruple-stage filtration system reaching a 0.04 µm final pore size, delivering low-particulate media suited to microfluidic and MPS platforms. RPMI 1640 with 0.1 µm mycoplasma-retentive filtration is well suited to immune cell OoC, tumor-immune interaction chips, and lymphocyte perfusion models.
 
This formulation intentionally omits sodium pyruvate (allowing researchers to define their own secondary carbon source), sodium bicarbonate (yielding a CO2-independent, HEPES-bufferable base suited to open-well and long-duration imaging protocols), and phenol red (removing a source of spectral interference in fluorescence and colorimetric assays). Supplement with sodium pyruvate (1 mM), HEPES (15–25 mM), or your preferred pH indicator as required by your protocol; contact support@diagnocine.com for custom pre-formulated variants.
No. This formulation is CO2-independent because sodium bicarbonate has been excluded. Supplement with HEPES (15–25 mM) for pH buffering in open-system or ambient-air culture.
Yes. Add FBS (5–10%), serum-free supplements, or growth factors as required for your assay. When adding serum or protein-containing supplements post-manufacture, filter through a 0.2 µm low-protein-binding PES or PVDF membrane (never 0.04 µm, which retains IgM, lipoproteins, and much of the functional serum fraction). Contact support@diagnocine.com for custom co-formulation.
FluxMPS™ DCP-RPMI-PBR1X is produced to meet a release specification of < 0.05 EU/mL by LAL assay (USP <85>). Endotoxin is controlled per manufacturing batch: every batch is tested before release and must meet this specification. For immune cell assays, elevated endotoxin can activate TLR4/NF-κB signaling, inducing cytokine release and altering lymphocyte activation state independently of experimental conditions.
Yes. A full CoA is available per batch, covering: appearance, pH (USP <791>), osmolality (USP <785>), sterility (USP <71>), endotoxin (USP <85>), mycoplasma filtration status, particulate count (USP <788> Method 1), and raw-material traceability. Request at support@diagnocine.com.
Scientific References

Supporting literature

Key publications supporting RPMI 1640 in immune cell culture and organ-on-a-chip applications.

  1. Moore GE, et al. Culture of normal human leukocytes. JAMA. 1967;199:519–524. doi:10.1083/jcb.1.3.273
  2. Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
  3. Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
  4. Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
  5. Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
  6. Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
  7. Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
  8. Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j

Satisfaction
Quality Rating
Value Rating
Style Rating
X